CORE D: BIOMARKER CORE
CORE D: BIOMARKER CORE
批准号:
10259844
负责人:
Peyton Jacob
金额:
$19.34万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-19 至 2023-08-31
关键词:
AerosolsAlkaloidsAnalytical ChemistryAnimalsBehaviorBiologicalBiological AssayBiological MarkersChemicalsCollaborationsCommunicationComplexDevelopmentElectronic cigaretteEmerging Tobacco ProductsExposure toFosteringGoalsGoldHealthIn VitroIndividualLaboratoriesLeadMass FragmentographyMeasuresMethodsPoisonProtocols documentationRegulationResearchResearch PersonnelResearch PriorityRiskSamplingSystemTobaccoTobacco useToxicologyanalytical methodbehavioral economicsbiomarker developmentexperienceheated tobacco productsimprovedinterestmass spectrometernicotine exposureproduct developmenttobacco exposuretobacco products
中文摘要
项目总结/摘要
暴露评估对于评估烟草使用的健康影响是必要的。测量暴露于
有毒和成瘾物质对于实现TCORS的综合主题非常重要,
了解综合的健康影响、行为和影响分析将提供可操作的信息
对当前和新兴烟草产品的监管和公众沟通
我将通过三个具体目标来实现这一目标:(1)为UCSF提供分析化学支持
TCORS调查员;(2)通过提供最新的信息,继续并扩大跨TCORS合作。
艺术分析方法来促进此类合作;(3)开发新的烟草暴露生物标志物
产品.生物标志物核心将确定新的生物标志物的暴露和潜在的伤害,
新兴烟草产品,特别是电子烟和加热不燃烧(HNB)产品。生物标志物核心
将支持TCORS研究人员通过分析生物流体样本的生物标志物进行的研究,
暴露和潜在危害(项目1-4),并通过分析烟草产品(电子烟和HNB
产品)及其气溶胶(项目1-3)的有害和潜在有害化学品(HPHC)。雅各布博士
他的高级实验室工作人员在支持大规模研究方面拥有30多年的经验,
开发新的生物标志物和分析方法。生物标志物核心实验室将测量烟草
生物碱和广泛的有毒物质和其他成分的利益,在这两个产品及其
气溶胶核心将协助项目1、2和3的调查人员执行协议,
产生用于化学分析和递送到体外系统和动物用于毒理学研究的气溶胶。
生物标志物核心采用的分析方法主要是色谱-质谱法
(GC-MS和LC-MS/MS)在三重四极杆质谱仪上进行,通常被认为是金
用于复杂生物样品定量分析的标准品。在我们目前的TCORS中,生物标志物核心
还希望使用其方法与其他TCORS超越加州大学旧金山分校的合作。提供最先进的
对个别项目进行风险评估,制定更好的风险评估措施,以及
确定新的和新兴的烟草产品及其气溶胶中导致有毒物质的物质
暴露也有助于制定潜在风险降低产品的产品标准,
作为推进烟草暴露评估领域的一般。
英文摘要
PROJECT SUMMARY/ABSTRACT
Exposure assessment is necessary for evaluating the health effects of tobacco use. Measuring exposure to
toxic and addictive substances is important for achieving the integrative theme of this TCORS, that
understanding combined health effects, behavior, and impact analysis will provide actionable information
for regulation of and public communications about current and emerging tobacco products The Biomarker Core
will contribute to this goal through three specific aims: (1) Provide analytical chemistry support for UCSF
TCORS investigators; (2) Continue and expand cross-TCORS collaborations by making available state-of-the-
art analytical methods to foster such collaborations; (3) Develop new biomarkers of exposure to tobacco
products. The Biomarker Core will identify new biomarkers of exposure and potential harm for new and
emerging tobacco products, in particular e-cigarettes and heat-not-burn (HNB) products. The Biomarker Core
will support studies carried out by TCORS investigators by analysis of biofluid samples for biomarkers of
exposure and potential harm (Projects 1-4), and by analyzing tobacco products (e-cigarettes and HNB
products) and their aerosols (Projects 1-3) for harmful and potentially harmful chemicals (HPHCs). Dr. Jacob
and his senior laboratory staff have more than 30 years' experience in supporting large-scale studies and
developing new biomarkers and analytical methods. The Biomarker Core laboratory will measure tobacco
alkaloids and a wide range of toxic substances and other components of interest in both products and their
aerosols. The core will assist the investigators of Projects 1, 2, and 3 in implementing protocols that will
generate aerosols for chemical analysis and for delivery to in vitro systems and animals for toxicology studies.
The analytical methods employed by the Biomarker Core are mostly chromatographic–mass spectrometric
(GC-MS and LC-MS/MS) performed on triple quadrupole mass spectrometers, generally considered the gold
standard for quantitative analysis of complex biological samples. As in our current TCORS, the Biomarker Core
also expects to use its methods in collaborations with other TCORS beyond UCSF. Providing state-of-the-art
exposure assessment to the individual projects, developing improved exposure assessment measures, and
identifying substances in new and emerging tobacco products and their aerosols that lead to toxic substance
exposure could contribute to the development of product standards for potential reduced risk products, as well
as advance the field of tobacco exposure assessment in general.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core C: Biomarkers p426-450
-
批准号:8592344
-
项目类别:
-
资助金额:$86.01万
-
财政年份:2013
-
负责人:Peyton Jacob
-
依托单位:
CORE D: BIOMARKER CORE
-
批准号:10468890
-
项目类别:
-
资助金额:$17.51万
-
财政年份:2013
-
负责人:Peyton Jacob
-
依托单位:
Liquid Chromatograph-Triple Quadrupole Mass Spectrometer
-
批准号:7792007
-
项目类别:
-
资助金额:$44.8万
-
财政年份:2010
-
负责人:Peyton Jacob
-
依托单位:
Administrative Core
-
批准号:10205005
-
项目类别:
-
资助金额:$18.72万
-
财政年份:1999
-
负责人:Peyton Jacob
-
依托单位:
Drug Dependence Clinical Research Program
-
批准号:10205003
-
项目类别:
-
资助金额:$78.29万
-
财政年份:1999
-
负责人:Peyton Jacob
-
依托单位:
Administrative Core
-
批准号:10627880
-
项目类别:
-
资助金额:$18.72万
-
财政年份:1999
-
负责人:Peyton Jacob
-
依托单位:
Drug Dependence Clinical Research Program
-
批准号:10025048
-
项目类别:
-
资助金额:$78.29万
-
财政年份:1999
-
负责人:Peyton Jacob
-
依托单位:
Drug Dependence Clinical Research Program
-
批准号:10627879
-
项目类别:
-
资助金额:$78.29万
-
财政年份:1999
-
负责人:Peyton Jacob
-
依托单位:
Research Support Core
-
批准号:10205006
-
项目类别:
-
资助金额:$51.94万
-
财政年份:1999
-
负责人:Peyton Jacob
-
依托单位:
Administrative Core
-
批准号:10417191
-
项目类别:
-
资助金额:$18.72万
-
财政年份:1999
-
负责人:Peyton Jacob
-
依托单位:
Research Support Core
-
批准号:10417192
-
项目类别:
-
资助金额:$51.94万
-
财政年份:1999
-
负责人:Peyton Jacob
-
依托单位:
Research Support Core
-
批准号:10627884
-
项目类别:
-
资助金额:$51.94万
-
财政年份:1999
-
负责人:Peyton Jacob
-
依托单位:
Drug Dependence Clinical Research Program
-
批准号:10417190
-
项目类别:
-
资助金额:$78.29万
-
财政年份:1999
-
负责人:Peyton Jacob
-
依托单位:
Research Support Core
-
批准号:10025050
-
项目类别:
-
资助金额:$51.94万
-
财政年份:--
-
负责人:Peyton Jacob
-
依托单位:
Core C: Biomarkers p426-450
-
批准号:8754525
-
项目类别:
-
资助金额:$37.88万
-
财政年份:--
-
负责人:Peyton Jacob
-
依托单位:
Administrative Core
-
批准号:10025049
-
项目类别:
-
资助金额:$18.72万
-
财政年份:--
-
负责人:Peyton Jacob
-
依托单位:
Core C: Biomarkers p426-450
-
批准号:8920111
-
项目类别:
-
资助金额:$43.72万
-
财政年份:--
-
负责人:Peyton Jacob
-
依托单位:
国内基金
海外基金
Iboga alkaloids骨架导向的不对称串联反应构建吖庚环并[4,5-b]吲哚及其在全合成中的应用
-
批准号:21801032
-
项目类别:青年科学基金项目
-
资助金额:26.0万元
-
批准年份:2018
-
负责人:陈惠渝
-
依托单位: